PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsRelapsing-remitting multiple sclerosis
MeSH D020529 - relapsing-remitting multiple sclerosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009103:Multiple sclerosis
159 Companies
33 Drugs
$
Success rate
D020529: 
Relapsing-remitting multiple sclerosis
36 Companies
11 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaGlatiramer acetate Copaxone  1996-12-20 $590 M Y2023 
Fingolimod Fingolimod  2020-07-02   
Teriflunomide Teriflunomide  2018-09-04   
Dimethyl fumarate Dimethyl Teva  2022-12-12   
Glenmark PharmaceuticalsFingolimod Fingolimod  2020-06-18   
Teriflunomide Teriflunomide  2018-11-15   
MylanFingolimod Fingolimod  2021-01-19   
Fingolimod Fingolimod Mylan  2021-08-18   
Glatiramer acetate Glatiramer  2017-10-03   
Teriflunomide Teriflunomide  2020-02-28   
Teriflunomide Teriflunomide Mylan  2022-11-09   
Dimethyl fumarate Dimethyl Mylan  2022-05-13   
Vanda PharmaceuticalsPonesimod Ponvory 2024-11-16 2021-03-18 $21.308 M Y2024 
Johnson & JohnsonPonesimod Ponvory  2021-05-19   
SandozGlatiramer acetate Glatopa  2015-04-16   
Teriflunomide Teriflunomide  2019-01-03   
Natalizumab Tyruko  2023-09-22   
NovartisFingolimod Gilenya 2026-03-29 2010-09-21 $1,683 M Q2/21-Q2/24 
Ofatumumab Kesimpta  2021-03-26 $1,593 M Q2/21-Q2/24 
Siponimod Mayzent  2020-01-13 $282 M Q2/20-Q2/23 
SanofiTeriflunomide Aubagio 2026-09-12 2012-09-12   
Aurobindo PharmaTeriflunomide Teriflunomide  2018-10-26   
Fingolimod Fingolimod  2024-02-28   
Dr Reddys LaboratoriesFingolimod Fingolimod  2021-03-05   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
68%
15/22
Phase 2
41%
29/70
Phase 3
61%
47/77
Approved: 13Overall Success rate: 17%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Glatiramer acetate,
Interferon beta,
Laquinimod,
Corticoids,
Manitol,
Fmx101
Johnson & Johnson
Ponesimod
Novartis
Siponimod,
Fingolimod,
Ofatumumab,
Siponimod fumaric acid,
Siponimod fumarate,
Interferon beta,
Escitalopram,
Remibrutinib,
Ademetionine,
Edrecolomab,
Ianalumab,
Sodium lactate,
Bevifimod,
Microcrystalline cellulose,
Corticoids,
Fluzone,
Lexapro,
Pneumovax,
Solumedrol,
Flumist,
Flucelvax,
Prevenar
Sanofi
Teriflunomide,
Interferon beta,
Benzocaine,
Tolebrutinib,
Ademetionine,
Terfenadine,
Dexibuprofen,
Lysine,
Sodium lactate,
Vatelizumab,
Microcrystalline cellulose,
Solumedrol,
Antacid,
Evidence
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use